Related Experiment Video

Updated: May 4, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

20.3K

GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2

Liquan Yang1, Scott Friedland, Nancy Corson

  • 1Authors' Affiliation: Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, New York.

Cancer Research
|December 21, 2013
PubMed

Insights

The GPR56 receptor inhibits melanoma by degrading tissue transglutaminase (TG2), a protein that promotes tumor growth. This interaction reduces extracellular matrix deposition, offering potential therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Extracellular matrix (ECM) accumulation is a key feature of the tumor microenvironment, influencing tumor progression.
  • The G protein-coupled receptor GPR56 is known to inhibit melanoma growth.
  • Tissue transglutaminase (TG2) is a major ECM crosslinking enzyme implicated in tumor progression.

Purpose of the Study:

  • To investigate the role of TG2 in GPR56-mediated melanoma inhibition.
  • To elucidate the functional relationship between GPR56 and TG2 in the context of melanoma.
  • To explore the therapeutic potential of targeting the GPR56-TG2 interaction.

Main Methods:

  • Xenograft studies were conducted in immunodeficient mice lacking TG2 (Tg2(-/-)).
  • Analysis of ECM deposition, specifically fibronectin.
  • Assessment of focal adhesion kinase accumulation and cell-ECM adhesion.

Main Results:

  • An antagonistic relationship between GPR56 and TG2 in melanoma was identified.
  • GPR56 antagonizes TG2's pro-tumorigenic activity by internalizing and degrading TG2.
  • GPR56-mediated TG2 downregulation led to decreased fibronectin deposition and impaired focal adhesion kinase accumulation, affecting cell-ECM adhesion.

Conclusions:

  • TG2 plays a significant role in GPR56-mediated melanoma inhibition.
  • The GPR56-TG2 interaction regulates ECM deposition and cell-ECM adhesion.
  • This antagonistic mechanism offers a potential strategy for reversing ECM accumulation in tumors, suggesting therapeutic applications for cancer treatment.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

12.4K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K